The association of OGG1 Ser326Cys polymorphism and urinary 8-OHdG levels with lung cancer susceptibility: A hospital-based case-control study in Turkey

Arhiv za Higijenu Rada i Toksikologiju

Volumn 59, Issue 4, 2008, Pages 241-250

  Karahalil, Bensu ^a   Emerce, Esra ^a   Koçer, Bülent ^b   Han, Serdar ^b   Alkiş, Necati ^c   Karakaya, Ali Esat ^a  

^a GAZI UNIVERSITY   (Turkey)

^b ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c ANKARA ONCOLOGY EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Disease; ELISA; Genetic variation; Oxidative stress; Pharmacogenomic; RFLP

Indexed keywords

8 HYDROXYGUANINE; 8 HYDROXYGUANINE DNA GLYCOSYLASE 1; CYSTEINE; DNA GLYCOSYLTRANSFERASE; SERINE; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HETEROZYGOSITY; HUMAN; LUNG CANCER; MALE; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; TURKEY (REPUBLIC); URINALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DEOXYGUANOSINE; DNA GLYCOSYLASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SMOKING; YOUNG ADULT;

EID: 57449091704     PISSN: 00041254     EISSN: None     Source Type: Journal    
DOI: 10.2478/10004-1254-59-2008-1924     Document Type: Article

References (41)

1. Minna JD, Roth JA, Gazdar AF. Focus on lung cancer. Cancer Cell 2002;1:149-52.
2. Howe HL, Wingo PA, Thun MJ, Ries LA, Rosenberg H, Feigal E, Edwards BK. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 2001;93:824-42.
3. Bilello KS, Murin S, Matthay RA. Epidemiology, etiology, and prevention of lung cancer. Clin Chest Med 2002;23:1-25.
4. Turkish Ministry of Health. Cancer statistics according to years 1999 [displayed 28 April 2007] available at http://www.saglik.gov.tr/TR/BelgeGoster. aspx?F6E10F8892433CFF71BE64510F6C8BC92747D9FFFE7A1226.
5. Littman AJ, Thornquist MD, White E, Jackson LA, Goodman GE, Vaughan TL. Prior lung disease and risk of lung cancer in a large prospective study. Cancer Causes Control 2004;15:819-27.
6. Loft S, Poulsen HE. Cancer risk and oxidative DNA damage in man. J Mol Med 1997;75:67-8.
7. Eva Y, Lee HP. Tumor suppressor genes: a new era for molecular genetic studies of cancer. Breast Cancer Res Treat 1991;19:3-13.
8. Hoffmann H, Isner C, Högel J, Speit G. Genetic polymorphisms and the effect of cigarette smoking in the comet assay. Mutagenesis 2005;20:359-64.
9. Karahalil B, Kocabas NA. OGG1 Ser326Cys genetic polymorphism in a Turkish population. Arch Toxicol 2005;79:377-80.
10. David SS. Structural biology: DNA search and rescue. Nature 2005;434:569-70.
11. Kasai H. Analysis of a form of oxidative DNA damage 8-hydroxy-2′- deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res 1997;387:147-63.
12. Karahalil B, Hogue BA, de Souza-Pinto NC, Bohr VA. Base excision repair capacity in mitochondria and nuclei: tissue-specific variations. FASEB J 2002;16:1895-902.
13. Xing DY, Tan W, Song N, Lin DX. Ser326Cys polymorphism in OGG1 gene and risk of esophageal cancer in a Chinese population. Int J Cancer 2001;95:140-3.
14. Kohno T, Shinmura K, Tosaka M, Tani M, Kim S, Sugimura H, Nohmi T, Kasai H, Yokota J. Genetic polymorphisms and alternative splicing of the OGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene 1998;16:3219-25.
15. Vogel U, Olsen A, Wallin H, Overvad K, Tjonneland A, Nex BA. No Association between OGG1 Ser326Cys and Risk of Basal Cell Carcinoma. CEBP 2004;13:1680-1.
16. Xu J, Zheng SL, Turner A, Isaacs SD, Wiley KE, Hawkins GA, Chang BL, Bleeckeri ER, Walsh PC, Meyers DA, Isaacs WB. Associations between OGG1 sequence variants and prostate cancer susceptibility. Cancer Res 2002;62:2253-7.
17. Sugimura H, Kohno T, Wakai K, Nagura K, Genka K, Igarashi H, Morris BJ, Baba S, Ohno Y, Gao C, Li Z, Wang J, Takezaki T, Tajima K, Varga T, Sawaguchi T, Lum JK, Martinson JJ, Tsugane S, Iwamasa T, Shinmura K, Yokota J. OGG1 Ser326Cys polymorphism and lung cancer susceptibility. CEBP 1999;8:669-74.
18. Kohno T, Sakiyama T, Kunitoh H, Goto K, Nishiwaki Y, Saito D, Sasaki-Matsumura R, Mimaki S, Toyama K, Yamamoto S, Kuchiba A, Sobue T, Ohta T, Ohki M, Yokota J. Association of polymorphisms in the MTH1 gene with small cell lung carcinoma risk. Carcinogenesis 2006;27:2448-54.
19. Wikman H, Risch A, Klimek F, Schmezer P, Spiegelhalder B, Dienemann H, Kayser K, Schulz V, Drings P, Bartsch H. OGG1 polymorphism and loss of heterozygosity (LOH): Significance for lung cancer susceptibility in a caucasian population. Int J Cancer 2000;88:932-7.
20. Lan Q, Mumford JL, Shen M, DeMarini DM, Bonner MR, He X, Yeager M, Welch R, Chanock S, Tian L, Chapman RS, Zheng T, Keohavong P, Caporaso N, Rothman N. Oxidative damage-related genes AKR1C3 and OGG1 modulate risks for lung cancer due to exposure to PAH-rich coal combustion emissions. Carcinogenesis 2004;25:2177-81.
21. Marchand LL, Donlon F, Lum-Jones A, Seifried A, Wilkens LR. Association of the OGG1 Ser326Cys polymorphism with lung cancer risk. CEBP 2002;11:409-12.
22. De Ruyck K, Szaumkessel M, De Rudder I, Dehoorne A, Vral A, Claes K, Velghe A, Van Meerbeeck J, Thierens H. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk. Mutation Res 2007;631:101-10.
23. Forgacs E, Zöchbauer-Müller S, Olah E, Minna JD. Molecular genetic abnormalities in the pathogenesis of human lung cancer. Pathol Oncol Res 2001;7:6-13.
24. Hussain SP, Haris CC. Molecular epidemiology of human cancer: Contribution of mutation spectra studies of tumor suppressor genes. Cancer Res 1998;58:4023-37.
25. Lu R, Nash HM, Verdine GL. A mammalian DNA repair enzyme that excises oxidatively damaged guanines maps to a locus frequently lost in lung cancer. Current Biol 1997;7:397-407.
26. Karahalil B, Kocabas NA, Ozcelik T. DNA repair gene polymorphism and bladder cancer susceptibility in a Turkish population. Anticancer Res 2006;26:4955-8.
27. Park J, Chen L, Tockman MS, Elahi A, Lazarus P. The human 8-oxoguanine DNA N-glycosylase 1 (OGG1) DNA repair enzyme and its association with lung cancer risk. Pharmacogentics 2003;14:103-9.
28. Zhang Y, Newcomb PA, Egan KM, Titus-Ernstoff L, Chanock S, Welch R, Brinton LA, Lissowska J, Bardin-Mikolajczak A, Peplonska B, Szeszenia-Dabrowska N, Zatonski W, Garcia-Closas M. Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. CEBP 2006;2:353-8.
29. Nock NL, Cicek MS, Li L, Liu X, Rybicki BA, Moreira A, Plummer SJ, Casey G, Witte JS. Polymorphisms in estrogen bioactivation, detoxification and oxidative DNA base excision repair genes and prostate cancer risk. Carcinogenesis 2006;27:1842-8.
30. Rossner P, Terry MB, Gammon MD, Zhang FF, Teitelbaum SL, Eng SM, Sagiv SK, Gaudet MM, Neugut AI, Santella RM. OGG1 Polymorphisms and breast cancer risk. CEBP 2006;15:811-5.
31. Smart DJ, Chipman JK, Hodges NJ. Activity of OGG1 variants in the repair of pro-oxidant-induced 8-oxo-2′-deoxyguanosine. DNA Repair 2006;5:1337-45.
32. Vodicka P, Stetina R, Polakova V, Tulupova E, Naccarati A, Vodickova L, Kumar R, Hanova M, Pardini B, Slyskova J, Musak L, De PG, Soucek P, Hemminki K. Association of DNA repair polymorphisms with DNA repair functional outcomes in healthy human subjects. Carcinogenesis 2006;28:657-64.
33. Janssen K, Schlink K, Gotte W, Hippler B, Kaina B, Oesch F. DNA repair activity of 8-oxoguanine DNA glycosylase 1 (OGG1) in human lymphocytes is not dependent on genetic polymorphism Ser326/Cys326. Mutation Res 2001;486:207-16.
34. Hung RJ, Hall J, Brennan P, Boffetta P. Genetic polymorphisms in the base excision repair pathway and cancer risk: a huge review. Am J Epidemiol 2005;162:925-42.
35. Paz-Elizur T, Krupsky M, Blumenstein S, Elinger D, Schechtman E, Livneh Z. DNA repair activity for oxidative damage and risk of lung cancer. J Natl Cancer Inst 2003;95:1312-9.
36. Hung RJ, Brennan P, Canzian F, Szeszenia-Dabrowska N, Zaridze D, Lissowska J, Rudnai P, Fabianova E, Mates D, Foretova L, Janout V, Bencko V, Chabrier A, Borel S, Hall J, Boffetta P. Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study. J Natl Cancer Inst 2005;97:567-76.
37. Vogel U, Nexø BA, Wallin H, Overvad K, Tjønneland A, Raaschou-Nielsen O. No association between base excision repair gene polymorphisms and risk of lung cancer, Biochem Genet 2004;42:453-60.
38. Sørensen M, Raaschou-Nielsen O, Hansen RD, Tjønneland A, Overvad K, Vogel U. Interactions between the OGG1 Ser326Cys polymorphism and intake of fruit and vegetables in relation to lung cancer. Free Radic Res 2006;40:885-91.
39. Ito H, Hamajima N, Takezaki T, Matsuo K, Tajima K, Hatooka S, Mitsudomi T, Suyama M, Sato S, Ueda RA. Limited association of OGG1 Ser326Cys polymorphism for adenocarcinoma of the lung. J Epidemiol 2002;12:258-65.
40. Loft S, Svoboda P, Kasai H, Tjønneland A, Vogel U, Moller P, Overvad K, Raaschou-Nielsen O. Prospective study of 8-oxo-7,8-dihydro-20- deoxyguanosine excretion and the risk of lung cancer. Carcinogenesis 2006;27:1245-50.
41. Erhola M, Toyokuni S, Okada K, Tanaka T, Hiai H, Ochi H, Uchida K, Osawa T, Nieminen MM, Alho H, Kellokumpu-Lehtinen P. Biomarker evidence of DNA oxidation in lung cancer patients: association of urinary 8-hydroxy-2′- deoxyguanosine excretion with radiotherapy, chemotherapy, and response to treatment. FEBS Letters 1997;409:287-91.